BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 30054538)

  • 1. Inflammatory response of microglia to prions is controlled by sialylation of PrP
    Srivastava S; Katorcha E; Makarava N; Barrett JP; Loane DJ; Baskakov IV
    Sci Rep; 2018 Jul; 8(1):11326. PubMed ID: 30054538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region-Specific Sialylation Pattern of Prion Strains Provides Novel Insight into Prion Neurotropism.
    Makarava N; Chang JC; Baskakov IV
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
    Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
    J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated inhibition of integrin α5β1 blocks neurotoxic prion peptide PrP106-126-induced activation of BV2 microglia.
    Chang J; Yang L; Kouadir M; Peng Y; Zhang S; Shi F; Zhou X; Yin X; Zhao D
    J Mol Neurosci; 2012 Sep; 48(1):248-52. PubMed ID: 22648512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow Cytometric Detection of PrP
    Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
    Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
    PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible off and on switching of prion infectivity via removing and reinstalling prion sialylation.
    Katorcha E; Daus ML; Gonzalez-Montalban N; Makarava N; Lasch P; Beekes M; Baskakov IV
    Sci Rep; 2016 Sep; 6():33119. PubMed ID: 27609323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation.
    Hughes MM; Field RH; Perry VH; Murray CL; Cunningham C
    Glia; 2010 Dec; 58(16):2017-30. PubMed ID: 20878768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype.
    Pankiewicz JE; Lizińczyk AM; Franco LA; Diaz JR; Martá-Ariza M; Sadowski MJ
    Acta Neuropathol Commun; 2021 Sep; 9(1):157. PubMed ID: 34565486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of sialylation of N-linked glycans in prion pathogenesis.
    Makarava N; Baskakov IV
    Cell Tissue Res; 2023 Apr; 392(1):201-214. PubMed ID: 35088180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.
    Katorcha E; Makarava N; Savtchenko R; Baskakov IV
    Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal activation of microglia accompanied with disrupted CX3CR1/CX3CL1 pathway in the brains of the hamsters infected with scrapie agent 263K.
    Xie WL; Shi Q; Zhang J; Zhang BY; Gong HS; Guo Y; Wang SB; Xu Y; Wang K; Chen C; Liu Y; Dong XP
    J Mol Neurosci; 2013 Nov; 51(3):919-32. PubMed ID: 23526370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Situ Temporospatial Characterization of the Glial Response to Prion Infection.
    Michael AV; Greenlee JJ; Harm TA; Moore SJ; Zhang M; Lind MS; Greenlee MHW; Smith JD
    Vet Pathol; 2020 Jan; 57(1):90-107. PubMed ID: 31331254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte activation gene 3 (Lag3) expression is increased in prion infections but does not modify disease progression.
    Liu Y; Sorce S; Nuvolone M; Domange J; Aguzzi A
    Sci Rep; 2018 Oct; 8(1):14600. PubMed ID: 30279468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialylation Controls Prion Fate
    Srivastava S; Katorcha E; Daus ML; Lasch P; Beekes M; Baskakov IV
    J Biol Chem; 2017 Feb; 292(6):2359-2368. PubMed ID: 27998976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement 3
    Hartmann K; Sepulveda-Falla D; Rose IVL; Madore C; Muth C; Matschke J; Butovsky O; Liddelow S; Glatzel M; Krasemann S
    Acta Neuropathol Commun; 2019 May; 7(1):83. PubMed ID: 31118110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited understanding of the functional diversity of N-linked glycans as a major gap of prion biology.
    Baskakov IV
    Prion; 2017 Mar; 11(2):82-88. PubMed ID: 28324664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyses of N-linked glycans of PrP
    Katorcha E; Baskakov IV
    FEBS J; 2017 Nov; 284(21):3727-3738. PubMed ID: 28898525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of microglia by retroviral infection correlates with transient clearance of prions from the brain but does not change incubation time.
    Muth C; Schröck K; Madore C; Hartmann K; Fanek Z; Butovsky O; Glatzel M; Krasemann S
    Brain Pathol; 2017 Sep; 27(5):590-602. PubMed ID: 27558169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion strain-dependent differences in conversion of mutant prion proteins in cell culture.
    Atarashi R; Sim VL; Nishida N; Caughey B; Katamine S
    J Virol; 2006 Aug; 80(16):7854-62. PubMed ID: 16873242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.